ASO targeting RBM3 temperature‐controlled poison exon splicing prevents neurodegeneration in vivo

Abstract Neurodegenerative diseases are increasingly prevalent in the aging population, yet no disease‐modifying treatments are currently available. Increasing the expression of the cold‐shock protein RBM3 through therapeutic hypothermia is remarkably neuroprotective. However, systemic cooling poses...

Full description

Saved in:
Bibliographic Details
Main Authors: Marco Preußner, Heather L Smith, Daniel Hughes, Min Zhang, Ann‐Kathrin Emmerichs, Silvia Scalzitti, Diego Peretti, Dean Swinden, Alexander Neumann, Tom Haltenhof, Giovanna R Mallucci, Florian Heyd
Format: Article
Language:English
Published: Springer Nature 2023-03-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.202217157
Tags: Add Tag
No Tags, Be the first to tag this record!